Bank of America
LFCR icon

Bank of America’s Lifecore Biomedical LFCR Stock Holding History

Bank of America’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161K Buy
43,298
+16,961
+64% +$117K ﹤0.01% 5428
2025
Q4 		$215K Buy
26,337
+9,053
+52% +$67K ﹤0.01% 5308
2025
Q3 		$127K Sell
17,284
-3,261
-16% -$24.7K ﹤0.01% 6493
2025
Q2 		$167K Sell
20,545
-6,717
-25% -$45.3K ﹤0.01% 6267
2025
Q1 		$192K Sell
27,262
-6,245
-19% -$38.8K ﹤0.01% 6199
2024
Q4 		$249K Buy
33,507
+6,776
+25% +$43.3K ﹤0.01% 6004
2024
Q3 		$132K Buy
26,731
+414
+2% +$2.16K ﹤0.01% 6209
2024
Q2 		$135K Buy
26,317
+9,216
+54% +$54.6K ﹤0.01% 6100
2024
Q1 		$90.8K Sell
17,101
-17,313
-50% -$124K ﹤0.01% 6287
2023
Q4 		$213K Buy
34,414
+3,543
+11% +$24.6K ﹤0.01% 6034
2023
Q3 		$233K Buy
30,871
+11,768
+62% +$108K ﹤0.01% 5817
2023
Q2 		$185K Sell
19,103
-19,024
-50% -$116K ﹤0.01% 5886
2023
Q1 		$144K Buy
38,127
+17,151
+82% +$95.6K ﹤0.01% 6096
2022
Q4 		$136K Buy
20,976
+11,440
+120% +$94.3K ﹤0.01% 6118
2022
Q3 		$85K Buy
9,536
+3,448
+57% +$35.1K ﹤0.01% 6419
2022
Q2 		$61K Sell
6,088
-4,703
-44% -$46.6K ﹤0.01% 6733
2022
Q1 		$125K Sell
10,791
-10,915
-50% -$122K ﹤0.01% 6740
2021
Q4 		$241K Buy
21,706
+3,359
+18% +$32.6K ﹤0.01% 6395
2021
Q3 		$169K Sell
18,347
-22,323
-55% -$243K ﹤0.01% 6416
2021
Q2 		$458K Sell
40,670
-38,577
-49% -$445K ﹤0.01% 5503
2021
Q1 		$840K Buy
79,247
+16,766
+27% +$188K ﹤0.01% 4995
2020
Q4 		$678K Sell
62,481
-11,358
-15% -$117K ﹤0.01% 4791
2020
Q3 		$718K Sell
73,839
-18,753
-20% -$179K ﹤0.01% 4452
2020
Q2 		$737K Buy
92,592
+4,332
+5% +$44.7K ﹤0.01% 4340
2020
Q1 		$767K Sell
88,260
-675
-0.8% -$7.02K ﹤0.01% 4190
2019
Q4 		$1.01M Sell
88,935
-42,775
-32% -$455K ﹤0.01% 4510
2019
Q3 		$1.43M Buy
131,710
+13,020
+11% +$142K ﹤0.01% 4307
2019
Q2 		$1.11M Buy
118,690
+8,957
+8% +$90.4K ﹤0.01% 4493
2019
Q1 		$1.35M Sell
109,733
-4,280
-4% -$52.3K ﹤0.01% 4290
2018
Q4 		$1.35M Buy
114,013
+66
+0.1% +$906 ﹤0.01% 4167
2018
Q3 		$1.64M Buy
113,947
+36,283
+47% +$502K ﹤0.01% 4142
2018
Q2 		$1.16M Sell
77,664
-6,112
-7% -$84.9K ﹤0.01% 4384
2018
Q1 		$1.09M Sell
83,776
-30,629
-27% -$402K ﹤0.01% 4322
2017
Q4 		$1.44M Sell
114,405
-6,840
-6% -$86.4K ﹤0.01% 4223
2017
Q3 		$1.57M Sell
121,245
-3,383
-3% -$44.6K ﹤0.01% 4180
2017
Q2 		$1.85M Buy
124,628
+2,333
+2% +$32.5K ﹤0.01% 3951
2017
Q1 		$1.47M Buy
122,295
+10,865
+10% +$138K ﹤0.01% 4141
2016
Q4 		$1.54M Sell
111,430
-8,039
-7% -$111K ﹤0.01% 3994
2016
Q3 		$1.6M Sell
119,469
-4,578
-4% -$55.4K ﹤0.01% 3815
2016
Q2 		$1.33M Buy
124,047
+3,435
+3% +$37.9K ﹤0.01% 3956
2016
Q1 		$1.27M Sell
120,612
-14,857
-11% -$163K ﹤0.01% 3940
2015
Q4 		$1.6M Buy
135,469
+16,681
+14% +$205K ﹤0.01% 3995
2015
Q3 		$1.39M Buy
118,788
+72,653
+157% +$963K ﹤0.01% 4087
2015
Q2 		$665K Sell
46,135
-15,423
-25% -$223K ﹤0.01% 4467
2015
Q1 		$859K Buy
61,558
+7,898
+15% +$109K ﹤0.01% 3886
2014
Q4 		$741K Sell
53,660
-51,627
-49% -$667K ﹤0.01% 4293
2014
Q3 		$1.29M Sell
105,287
-155,884
-60% -$1.95M ﹤0.01% 3780
2014
Q2 		$3.26M Sell
261,171
-136,918
-34% -$1.61M ﹤0.01% 2937
2014
Q1 		$4.44M Sell
398,089
-63,200
-14% -$693K ﹤0.01% 2506
2013
Q4 		$5.59M Sell
461,289
-5,686
-1% -$67.9K ﹤0.01% 2376
2013
Q3 		$5.7M Sell
466,975
-6,603
-1% -$92.1K ﹤0.01% 2279
2013
Q2 		$6.26M Buy
+473,578
New +$6.55M ﹤0.01% 2100

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's LFCR Position: Q1 2026 in Review

Bank of America increased its Lifecore Biomedical (LFCR) stake by 64% in Q1 2026, buying an estimated $117K and bringing the position to 43,298 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #5428.

Bank of America first reported a position in LFCR in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.26M in Q2 2013. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Bank of America held 43,298 shares of Lifecore Biomedical worth $161K as of Q1 2026.
  • Bank of America bought 16,961 Lifecore Biomedical shares in Q1 2026, an estimated $117K.
  • Lifecore Biomedical made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5428 holding.
  • Bank of America first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Lifecore Biomedical position peaked at $6.26M in Q2 2013.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.